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Abstract: Treatment and prevention of cattle mastitis remains a formidable challenge due to the
anatomical and physiological constraints of the cow udder. In this study, we investigated polymeric
excipients and solvents that can form, (when combined) novel, non-toxic and biocompatible in situ
gelling formulations in the mammary gland of bovine cattle. We also report on a new approach to
screen intramammary formulations using fresh excised cow teats. Fourteen hydrophilic polymers
and six solvents were evaluated for in vitro cytotoxicity and biocompatibility towards cultured
bovine mammary epithelial cells (MAC-T), microscopic and macroscopic examination upon contact
with excised cow teats. No significant cytotoxicity (p > 0.05) was observed with polyethylene
oxides, hydroxypropyl methylcellulose, carboxymethyl cellulose, sodium alginate and xanthan
gum. Polycarbophil and carbopol polymers showed significantly higher cytotoxicity (p < 0.05).
Concentration-dependent cytotoxicity was observed for glycerin, propylene glycol, polyethylene
glycol 400, ethanol, N-methyl-2-pyrrolidone and 2-pyrrolidone, with the 2-pyrrolidone solvents
showing higher cytotoxic effects (p < 0.05). In situ gelling formulations comprising hydroxypropyl
methylcellulose or carboxymethyl cellulose and solvents in specific ratios were biocompatible at
higher concentrations with MAC-T cells compared to alginates. All investigated formulations could
undergo in situ sol-to-gel phase transformation, forming non-toxic gels with good biocompatibility
in excised cow teats hence, showing potential for use as intramammary carriers for sustained
drug delivery.
Keywords: biocompatibility; in situ gelling intramammary formulations; cattle mastitis
1. Introduction
Bovine mastitis continues to be one of the major challenges facing the dairy cow
industry, causing heavy economic losses as a result of decreased milk production, reduced
fertility, treatment costs or death in instances of therapeutic failure [1].
Mastitis is the inflammation of the mammary gland; it occurs primarily in response
to intramammary bacterial infection in dairy cows amongst other aetiologies including
fungal and algal infection, mechanical, thermal or chemical trauma [2,3]. The increased
incidence of new infections is believed to occur mainly during the drying off or dry periods
when dairy cows are particularly susceptible to mastitis due to predisposing factors.
Subclinical pathogens which have survived in the udder from the previous lactation
may progress to manifest clinically after calving [4]. Furthermore, new infections caused
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by environmental pathogens, particularly the Staphylococcal strains including Streptococcus
uberis, Streptococcus dysgalactiae, as well as Corynebacterium bovis or E. coli, are more fre-
quent during the dry period. Staphylococcus aureus is the most common mastitis-causing
pathogen [5,6].The causative pathogens involved in mammary gland infections present the
greatest challenge in treating mastitis [7,8].
The pathogens isolated from mastitis-affected milk have been reported to exhibit
a wide spectrum of antibiotic susceptibility. Therefore, antibiotics are often routinely
administered to entire herds to treat mastitis, especially through intramammary infu-
sion [6]. However, the wide use of antibiotics for the treatment of mastitis has meant the
development of bacterial resistance to antibiotics. Several studies have assessed antibiotic
sensitivity/resistance. For instance, in a study conducted in the Zenica region in Bosnia
and Herzegovina, antimicrobial resistance was observed against benzylpenicillin (56.3%)
and oxytetracycline (46.2%) [9]. Similarly, antibiotic resistance and virulence genes in the
staphylococus strain was identified by Saidi et al. [6].
Since excessive use of antibiotics in dairy cows can contribute to increased antimi-
crobial resistance, further research must be directed towards the development of new
therapeutic agents/techniques that can both replace conventional techniques and also
solve the problem of emerging antibiotic resistance.
Some alternative approaches have concentrated on the treatment of mastitis by home-
opathy [5] and the use of feed additives [10]. Other treatment strategies for the treat-
ment/control of mastitis include dry cow therapy using external teat seals. Internal teat
inserts and internal teat seals have also been developed and marketed to overcome the
occurrence of mastitis.
The use of internal teat seals is indeed an effective strategy to prevent mastitis infection
during the dry period. When infused into each quarter of the drying off udder, they behave
in a similar way to a natural keratin plug in forming a barrier to environmental pathogens.
They are intended for retention for weeks, hence decreasing new intramammary infections
(IMIs) during the dry period [11,12]. Despite the success of teat seal products, inadequate
and poor retention followed by subsequent failure to seal the teat was reported [13].
Furthermore, excipients in current formulations include heavy metal salts such as
bismuth subnitrate [14–18] aluminum monostearate and mineral oils, for which there is
information on their undesirable effect on cells and tissues that they contact. For example,
bismuth subnitrate has been shown to induce neurotoxic effects in both humans and
animals [19] with reported side effects being encephalopathy, nephropathy, stomatitis and
colitis [20]. Moreover, some common vehicles are known to provoke inflammation and
irritation to the bovine udder which may breach the integrity of the mucosa and predispose
the udder quarters to infection [21].
To improve on some of the reported inadequacies of internal teat seals, we have
reported on novel in situ gelling polymeric dispersions consisting of infusible low-viscosity
blends of synthetic, semi-synthetic and naturally occurring polymers dispersed in different
organic solvents, which undergo a rapid sol to gel phase change induced by solvent
exchange (organic solvent–water) with the surrounding environment [22]. The system,
which transforms into a semi-solid mass at the administration site upon hydration of the
dispersed polymer, can assume the shape of the cavity where it is infused, forming a
barrier against microbial adhesion or pathogen ingress [23]. Furthermore, these systems
may serve as matrices for controlled delivery of drugs and bioactive compounds [22].
The phase behavior of various pseudoternary polymer/solvent blend/water systems,
was investigated and six in situ gelling formulations were identified as promising for
intramammary applications based on their rheological and mechanical properties.
These in situ gelling delivery systems are designed to come into intimate contact with
biological tissues over extended periods of time (weeks to months), hence the significance
of biocompatibility/cytotoxicity studies. The biocompatibility requirements for intramam-
mary systems are such that they should demonstrate the absence of a cytotoxic effect [24]
as well as biocompatibility and functionality, which contributes to the intended purpose of
Pharmaceutics 2021, 13, 1732 3 of 18
the system [25]. In addition, the system must be easily sterilizable during manufacture [24].
For this purpose, the International Organization for Standardization (ISO) guideline 10,993
specifies a series of standards for the evaluation of biocompatibility; it prioritizes cell
culture-based in vitro tests to precede clinical testing.
More recently, we reported on antibiotic-free solid polymeric inserts for the prevention
and/or treatment of bovine mastitis. Polyethylene oxide (PEO)-based inserts were prepared
using different concentrations of various hydrophilic polymers and water-soluble and
water-insoluble drug-release-modifying excipients [26].
This manuscript reports on the cytotoxicity and biocompatibility of hydrophilic poly-
mers, solvents and intramammary formulations [22,26] on bovine mammary epithelial
cells (MAC–T cells). Furthermore, a new method to screen intramammary formulations for
potential in situ gelling using freshly collected excised cow teats is described.
2. Materials and Methods
2.1. Materials
Dulbecco’s modified Eagle’s medium containing high glucose, L-glutamine, sodium
pyruvate, pyridoxine hydroxide, 0.25% Trypsin-Ethylenediamine-tetra acetic acid (EDTA),
penicillin G (5000 units/mL) and streptomycin sulfate (5000 µg/mL) was from Gibco BRL
(Carlsbad, CA, USA). Triton X-100 for cell lysis was from BDH chemicals (Poole, Dorset,
UK). Solvents, propylene glycol (PG), glycerol (G), polyethylene glycol 400 (PEG), N-methyl
2-pyrrolidone (NMP) and 2-pyrrolidone (2-Pyr) were purchased from Sigma chemicals
(St. Louis, MO, USA); ethanol from Scharlau Chemie S.A., (Barcelona, Spain); polymers,
polyethylene oxide (PEO, PolyoxTM, Bellevue, WA, USA) of different molecular weights
(MW 100 K, 1 M, 4 M and 7 M) from Dow Chemical (Midland, MI, USA); hydroxypropyl
methylcellulose (HPMC, Metolose 60 SH) from Shin-Etsu Chemical Co. Ltd., (Tokyo,
Japan); sodium alginate (ALG) and high-viscosity grade carboxymethyl cellulose sodium
(CMC) from BDH (Poole, Dorset, UK); xanthan gum (XG) from Jungbunzlauer GmbH,
(Basel, Switzerland); polycarbophil (PCP), polyvinyl pyrrolidone (PV) and carbopols (CP:
974P, 907 and 971P) from BF Goodrich (Cleveland, UK). Bovine mammary epithelial cells
(MAC-T) were kindly provided by AgResearch, Hamilton, New Zealand.
2.2. Preparation of Polymer and Solvent Systems
Polymers, polyethylene oxide (PEO, PolyoxTM) of different molecular weights 100,000,
1 M, 4 M and 7 M, hydroxypropyl methylcellulose (HPMC), sodium alginate (ALG),
carboxymethyl cellulose sodium (CMC), xanthan gum (XG), polyvinylpyrrolidone (PVP),
carbopols (974P, 907 and 971P) and polycarbophil (PCP) were prepared/dissolved in
culture media at a concentration of 10 mg/mL and left at 37 ◦C for 24 h to equilibrate. The
samples were further diluted with culture media to concentrations ranging from 0.05 to
1 mg/mL.
Solvents, glycerine (G), propylene glycol (PG), polyethylene glycol 400 (PEG), ethanol
(E), N-methyl 2-pyrrolidone (NMP) and 2-pyrrolidone (2-Pyr), were diluted to concen-
trations ranging from 0.1 to 10% v/v with culture media. The solutions of both polymers
and solvents were prepared under aseptic conditions and were neutralised, whenever
necessary, to physiological pH.
2.3. Preparation of Polymer/Solvent Intramamary Formulations
Polymer/solvent blends were aseptically prepared according to the compositions
shown in Table 1. Briefly, the binary solvents (G:E or G:PG) were mixed (according to
the ratios shown in Table 1) in glass beakers using a Heidolph star blade mixer (Nicholas
Watson Victor Ltd., Germany) at ~250 rpm speed. Thereafter, 10 g polymer (HPMC, CMC
or ALG) was slowly added while the mixture was stirred vigorously until polymer particles
were wetted and disaggregated. Finally, water was added under stirring until a uniform
suspension was produced. Test samples for cell culture studies were prepared by diluting
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each formulation blend with the culture medium to desired concentrations. The solutions
of the various blends were neutralised, whenever necessary, to physiological pH.
Table 1. Composition of polymer/solvent intramammary formulations.
Polymer/Solvent Blend Composition (% w/w)
Polymer Solvent
HPMC CMC ALG G E PG W
HPMC 1 10 49.5 22.5 18
HPMC 2 10 9 72 9
CMC 1 10 18 45 27
CMC 2 10 27 45 18
ALG 1 10 31.5 31.5 27
ALG 2 10 18 36 36
Key: HPMC—hydroxypropylmethyl cellulose, CMC—carboxymethyl cellulose sodium, ALG—sodium alginate,
G—glycerin, E—ethanol, PG—propylene glycol, W—water.
2.4. Cell Culture
MAC-T cells (passage number 8) were cultured in 75 cm2 tissue culture flasks (Nunc,
Roskilde, Denmark) and maintained in DMEM supplemented with 10% fetal calf serum
(FCS) (Invitrogen, Inchinnan, UK), penicillin G and streptomycin (100 IU/mL), 0.5% insulin
and 0.2% hydrocortisone. The cells were incubated at 37 ◦C in 5% CO2 until confluent at a
density of 0.1 × 105. Adherent cells were harvested using 0.25% Trypsin-0.05 mM EDTA.
Growth curves of cells were established, and the assays were performed in the exponential
growth phase.
In addition, cells were checked routinely by visual examination under an inverted
phase-contrast microscope (CKX53 Olympus, Tokyo, Japan) to monitor changes in mor-
phology and detachment of cells.
2.5. Celll Viability (MTT or MTS) Assay
The viability of MAC-T cells following exposure to test solutions of solvents, polymers
or polymer/solvent blends for 72 h was quantitatively measured using an MTT assay.
MAC-T cells were seeded onto 96-well plates (Corning Incorporated, NY, USA) at a
density of 3 × 103 cell/cm2. After 24 h, the media was discarded from the well and the
cells were washed with phosphate buffer saline (PBS). One hundred (100) µL of each test
solution (polymer, solvent or polymer/solvent blend prepared in culture media with 1%
FCS) was introduced into the well in triplicates and incubated for 72 h at 37 ◦C in 5% CO2.
Untreated controls (cells without test solutions) and background controls (media only)
were used as references.
After 72 h incubation, cell viability was quantitatively measured using 3-(4,5-dimethyl-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTT or MTS) com-
mercial assay EZ4U kit (Australian Laboratory Services) according to the manufacturer’s
instructions. The EZ4U cell proliferation assay reagent (TECO medical Group, Sissach,
Switzerland) (20 µL) was added to each well and the plates were further incubated for 4 h
at 37 ◦C in 5% CO2. Colourimetric readings of cooled 96-well plates were undertaken at
490 nm using a Model-ELX 800 UV microplate reader (Bio-Tek, Instruments Inc, Winooski,
VT, USA). The relative cell viability (%) was expressed as a percentage of the viability in
untreated wells.
2.6. Cytotoxicity (LDH) Assay
The LDH assay was performed using a cytotoxicity detection kit (Roche Diagnostics,
GmbH, Mannheim, Germany) according to the manufacturer’s protocol. Briefly, after
incubation of MAC-T cells in 96-well plates overnight, media was discarded, cells washed
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with PBS and the test solution (100 µL/well) added to each well. After incubation at 37 ◦C
in 5% CO2 for 72 h, plates were centrifuged at 250× g for 10 min and 50 µL of supernatant
was withdrawn from each well and added to wells in a new plate. LDH reagent (50 µL)
was added to each well. After 30 min incubation protected from light, absorbance values
were measured at 490 nm with the microplate reader. Maximum LDH release was also
measured using 1% Triton X-100 as high control (Hc) and cells without test substance were
used as low control (Lc). Cytotoxicity was determined as a percentage of High control (Hc)
after correcting for background absorbance.
2.7. In Situ Sol-to-Gel Formulation Transformation in Excised Bovine Teats
Teats were excised from the mammary glands of slaughtered cows and transferred
immediately to our lab. They were mounted in a purpose-made frame maintained in a
vertical position (Figure 1). Whole cow milk (2 mL) was introduced to each teat. Immedi-
ately thereafter, 3 mL of each polymer/solvent blend formulation was infused into the teat
cistern via the streak canal and left for 3 and 12 h while shaking at 50 rpm at room temper-
ature. Teats were cut open (at two time points of 3 and 12 h) and evaluated for evidence of
in situ gelling of the formulations. In addition, the mucosal tissue in direct contact with the
formulation was inspected for any undesirable events (redness, inflammation, pallor and
necrosis). Each polymer blend (HPMC 1, HPMC 2, CMC 1, CMC 2, ALG 1 and ALG 2) was
investigated in triplicate.
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Figure 1. New ex vivo setup to study in situ gelling, retention and biocompatibility of formulations in excised bovine teats.
2.8. Statistical Analysis
Statistical analyses for any differences between test and control samples were car-
ried out using one-way analysis of variance (ANOVA) (Minitab Release, version 12.1 for
Windows, Harrisburg, PA, USA). A Tukey’s pair wise comparison set at a 95% confidence
interval was performed.
3. Results
3.1. Morphology of Mac-T Cells
MAC-T cells (Figure 2) are produced from primary bovine mammary epithelial
cells [27]. The cells retain a number of biochemical and morphological characteristics
in vivo [27,28]. Huynh et al. reported that MAC-T cells possess the ability to differenti-
ate and secrete caseins, providing unique mammary epithelial cell function [29]. Hence,
MAC-T cells were selected as a mammary gland epithelium cell model for our biocompati-
bility studies.
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Figure 2. Light micrograph of MAC-T cells showing their characteristic morphology (100×magnification).
Cell culture showed a characteristic cobblestone morphology of epithelial cells (Figure 2).
Viable cells adhered to the surface of the flask and proliferated to produce various degrees
of confluency. After exposure to test solutions of polymers, solvents and formulation
blends, microscopic examinations were undertaken to establish changes, if any, to the
growth and morphology of the cells. In response to a toxic effect, cells become rounded
with a granular appearance and detach from the surface of the flask.
3.2. Effect of Polymer Dispersions on MAC-T Cells
The mitochondrial metabolic activity of viable MAC-T cells in the presence of polymers
at three different concentrations ranging from 0.1 to 1 mg/mL was determined using the
MTT assay. The cell viability as a function of polymer type and concentration is shown i
Figure 3.
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and carbopols (CP 907, CP 974P, CP 971P) polycarbophil (PCP).
PEO, HPMC, CMC, ALG and PVP solutions at the highest concentration of 1 mg/mL
showed no significant reduction in cell viability compared to the negative control (Figure 3).
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XG, at this concentration reduced cell viability to approximately 83% of control, but this
was statistically insignificant (p > 0.05). In contrast, cell viability decreased significantly
(p < 0.05) to about 45% relative to the negative control for CP and PCP polymers at 1 mg/mL
concentration.
At a lower concentration of 0.5 mg/mL, the cell viability following incubation with
PEO, CMC, HPMC, ALG, XG, PVP, CP 907, CP 974 and PCP was comparable with the
negative control. On the other hand, CP 971 at this concentration induced a significant
(p < 0.05) reduction in cell viability to ~68% of control.
At the lowest concentration of 0.1 mg/mL, all polymers, except CP 971 (p < 0.05),
showed no significant influence on cell viability compared to the negative control.
Of the polymers tested across the specified concentration ranges, only HPMC and
PVP had no effect on cell viability as determined by the MTT assay (Figure 3). All other
polymers demonstrated a response that was dependent on the polymer concentration to
varying degrees.
PEOs of varying molecular weights, CMC, ALG and XG produced relatively small,
statistically insignificant (p > 0.05) response fluctuations over the concentrations tested
while the CPs and PCP produced a much greater cell toxicity to the same tested variations
in polymer concentration.
Microscopic examination revealed that cells of the negative control wells adhered
to the surface and proliferated over the incubation period to produce their characteristic
morphology and confluence. The same was observed when incubated with HPMC and
PVP at concentrations (up to 1 mg/mL) that had no significant effect on cell viability
(Figure 4a). On the other hand, after exposure to high and toxic concentrations of CPs or
PCP, cells assumed a rounded shape with the appearance of cytoplasmic granules and had
detached from the surface of the flask to disrupt the characteristic ‘cobblestone’ punctate
morphology (Figure 4b) and floated in the media.
Pharmaceutics 2021, 13, x FOR PEER REVIEW 7 of 19 
 
 
PEO, HPMC, CMC, ALG and PVP solutions at the highest concentration of 1 mg/mL 
showed no significant reduction in cell viability compared to the negative control (Figure 
3). XG, at this concentration reduced cell viability to approximately 83% of control, but 
this was statistically insignificant (p > 0.05). In contrast, cell viability decreased signifi-
cantly (p < 0.05) to about 45% relative to the negative control for CP and PCP polymers at 
1 mg/mL concentration. 
At a lower concentration of 0.5 mg/mL, the cell viability following incubation with 
PEO, CMC, HPMC, ALG, XG, PVP, CP 907, CP 974 and PCP was comparable with the 
negative control. On the other hand, CP 971 at this concentration induced a significant (p 
< 0.05) reduction in cell viability to ~68% of control. 
At the lowest concentration of 0.1 mg/mL, all polymers, except CP 971 (p < 0.05), 
showed no significant influence on cell viability compared to the negative control. 
Of the polymers tested across the specified concentration ranges, only HPMC and 
PVP had no effect on cell viability as determined by the MTT assay (Figure 3). All other 
polymers demonstrated a response that was dependent on the polymer concentration to 
varying degrees. 
PEOs of varying molecular weights, C C, ALG and XG produced relatively small, 
statistically insignificant (p > 0.05) response fluctuations over the concentrations tested 
hile the CPs and PCP produced a uch greater cell toxicity to the sa e tested variations 
in poly er concentration. 
icrosco ic exa ination revealed that cells of the negative control wells adhered to 
the surface and proliferated over the incubation period t  r ce t eir characteristic 
r l   fl .  s  s s r   i t  it   a  
 t co centrations (up to 1 mg/mL) that had no significant effect on cell viability (Fig-
ure 4a). On the other and, after exposure to high and toxic concentrations of CPs or PCP, 
cells assumed a rounded shape with the appearance of cytoplasmic granules and had de-
tached from the surface of the flask to isr t   ‘  ct t  
  )  fl te  i  t e e ia. 
  
(a) (b) 
Figure 4. Cell morphology following exposure to polymer solution for 72 h. (a) Confluent adherent cells after exposure to 
HPMC (1 mg/mL) solution and (b) reduced cell viability after exposure to CP 971 (1 mg/mL) solution (40× magnification). 
In addition to the MTT assay, the lactate dehydrogenase (LDH) assay was also per-
formed as a measure of enzyme activity in the supernatant. The cytotoxicity of different 
concentrations of the various polymers on MAC-T cells following 72 h incubation is 
shown in Figure 5. 
Fig re 4. ell orphology follo ing exposure to poly er solution for 72 h. (a) onfluent a herent cells after exposure to
HPMC (1 mg/mL) solution and (b) reduced cell viability after exposure to CP 971 (1 mg/mL) solution (40× magnification).
, t l t t
f e acti it i the supernata t. c t t i it f iffere t
trations of the various polymers on MAC-T cells fo owing 72 h incubation is shown
in Figure 5.
In most cases, a concentration-dependent cytotoxic effect was observed following
incubation, depending on the polymer used. The level of toxicity for all polymers, except
PVP, increased with increasing polymer concentrations.
At the highest concentration of 1 mg/mL, all polymers showed a toxic effect on cells
as measured by the LDH assay, although enzyme release caused by HPMC, ALG and PVP
(9–12%) was significantly lower (p < 0.05) than PEO 303, PEO 301, PEO N 10, CMC and XG
(16–18%). Significantly higher LDH release (26–37%) was demonstrated by CP974, CP971
and PCP at 1 mg/mL relative to all other polymers (p < 0.05) following exposure to MAC-T
cells for 72 h.
Pharmaceutics 2021, 13, 1732 8 of 18




Figure 5. Cytotoxicity of polymer solutions on MAC-T cells after 72 h incubation as detected by the 
LDH assay (mean ± SD, n = 3). Black (0.1 mg/mL), grey (0.5 mg/mL) and white (1 mg/mL) bars depict 
the concentration of each polymer. The standard deviation is shown by the error bars. ▪ denotes 
significance from negative control. 
In most cases, a concentration-dependent cytotoxic effect was observed following in-
cubation, depending on the polymer used. The level of toxicity for all polymers, except 
PVP, increased with increasing polymer concentrations. 
At the highest concentration of 1 mg/mL, all polymers showed a toxic effect on cells 
as measured by the LDH assay, although enzyme release caused by HPMC, ALG and PVP 
(9–12%) was significantly lower (p < 0.05) than PEO 303, PEO 301, PEO N 10, CMC and 
XG (16–18%). Significantly higher LDH release (26–37%) was demonstrated by CP974, 
CP971 and PCP at 1 mg/mL relative to all other polymers (p < 0.05) following exposure to 
MAC-T cells for 72 h. 
3.3. Effect of Co-Solvents on MAC-T Cells Viability 
The cytotoxicity of co-solvents used in the study to MAC-T cells was determined by 
the MTT assay following 72 h incubation. The effect of the different concentrations of the 
various solvents on cell viability is presented in Figure 6. Solvents, G, PG and PEG were 
tested at concentrations ranging from 0.1–10% v/v while E, NMP and 2-Pyr were tested at 
concentrations ranging from 0.1–1% v/v. (Results for NMP and 2-Pyr at concentrations 













0.1 mg/ml 0.5 mg/ml 1 mg/ml
▪ ▪ ▪ ▪
▪ ▪ ▪
▪▪ ▪▪
Figure 5. Cytotoxicity of polymer solutions on MAC-T cells after 72 h incubation as detected by the LDH assay (mean ± SD,
n = 3). Black (0.1 mg/mL), grey (0.5 mg/mL) and white (1 mg/mL) bars depict the concentration of each polymer. The
standard deviation is shown by the error bars.  denotes significance from negative control.
3.3. Effect of Co-Solvents on MAC-T Cells Viability
The cytotoxicity of co-solvents us d in the stud t MAC-T cells was determined by
the MTT assay following 72 h incubation. The effect of the different concentrations of the
various s lvents on cell viability is presented in Figur 6. Solvents, G, PG and PEG were
tested at concentrations ranging from 0.1–10% v/v while E, NMP and 2-Pyr were tested at
concentrations ranging from 0.1–1% v/v. (Results for NMP and 2-Pyr at concentrations
above 1% are not shown due to n gligible cell viability at these concentrations).




Figure 6. MAC-T cell viability in various concentrations of different solvents after 72 h. Black, various grades of grey and 
white bars depict the concentration of each solvent ranging from 0.1, 0.25, 0.5, 1, 5 and 10%. Cell viability was detected by 
MTT assay and expressed as a percentage of viability of untreated control cells (mean ± SD, n = 3). The standard deviation 
is shown by the error bars. * denotes significance from negative control. (Legend: glycerin (G), propylene glycol (PG), 
polyethylene glycol 400 (PEG), ethanol (E), N-methyl-2-pyrrolidone (NMP) and 2-pyrrolidone (2-Pyr). 
All solvents tested showed a decreasing cell viability with increasing solvent concen-
tration. At the highest concentration of 10% v/v, G, PG and PEG reduced the cell viability 
significantly (p < 0.05). PG caused the greatest reduction in viable cells followed by G and 
then by PEG with cell viability being ~45, 60 and 67%, respectively. Decreasing the solvent 
concentration of all three solvents showed an accompanying increase in cell viability rel-
ative to control. 
Ethanol tested at concentrations increasing from 0.1 to 1% did not significantly de-
crease cell viability, while NMP and 2-Pyr demonstrated a concentration-dependent cell 
viability. At all concentrations of 2-Pyr and at concentrations above 0.25% of NMP, cell 
viability was adversely affected compared to untreated control samples (p < 0.05). 
In the LDH assay, a similar concentration-dependent cytotoxic effect was observed 
for the solvents after a 72 h incubation period with MAC-T cells (Figure 7). PG appeared 
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viability significantly (p < 0.05). PG caused the greatest reduction in viable cells followed
by G and then by PEG with cell viability being ~45, 60 and 67%, respectively. Decreasing
the solvent concentration of all three solvents showed an accompanying increase in cell
viability relative to control.
Ethanol tested at concentrations increasing from 0.1 to 1% did not significantly de-
crease cell viability, while NMP and 2-Pyr demonstrated a concentration-dependent cell
viability. At all concentrations of 2-Pyr and at concentrations above 0.25% of NMP, cell
viability was adversely affected compared to untreated control samples (p < 0.05).
In the LDH assay, a similar concentration-dependent cytotoxic effect was observed for
the solvents after a 72 h incubation period with MAC-T cells (Figure 7). PG appeared to be
more toxic compared to G and PEG. The LDH release due to PG at 10% concentration was
~50% compared to 33% for G and 22% for PEG. On the other hand, 2-Pyr and NMP were
highly toxic at 1% concentration where the membrane damage and enzyme leakage caused
by 2-Pyr was over 80% and ~65% from NMP. Ethanol did not show any significant toxicity
in MAC-T cells at the concentrations used in this study.




Figure 7. Cytotoxicity of co-solvents on MAC-T cells after 72 h incubation as detected by the LDH assay ((mean ± SD, n = 
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0.5, 1, 5 and 10%. The standard deviation is shown by the error bars. 
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3.4. Effect of Polymer/Solvent Formulations on Viability of MAC-T Cells
Six blends, HPMC1, HPMC2, CMC1, CMC2, ALG1 and ALG2 formulated according
to compositions shown in Table 1, were diluted with culture media to concentrations
ranging from 0.05 to 1 mg/mL. The viability of MAC-T cells, following exposure to these
varying concentrations of polymer-solvent blends, was assessed using the MTT assay; the
results are presented in Figure 8.
HPMC and CMC formulations at concentrations of up to 0.5 mg/mL did not exhibit
any reduction in MAC-T cell viability following 72 h, on the contrary, cells seem to prolif-
erate in their presence, although this observation should be taken with caution (Figure 8).
At a higher concentration of 1 mg/mL of HPMC 1, HPMC2 or CMC1, cell viability was
not compromised relative to untreated controls. However, CMC2 at this concentration
significantly decreased cell viability to about 74% (p < 0.05).
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A decreasing trend in cell viability was observed upon exposure of the MAC-T cells
to increasing concentrations of ALG 1 and ALG 2 formulations, with significant reductions
seen at 1 mg/mL for both formulations and at 0.5 mg/mL for ALG2.
The addition of water (Table 1) to the polymer/solvent mixture is pivotal to induce the
desirable sol-to-gel phase change and the subsequent emergence of previously described
microstructures [22]. Consequently, the biocompatibility of the formulations was evaluated.
Results obtained with the MTT assay showed that formulations HPMC 1, HPMC 2 and
CMC 1 did not reduce MAC-T cell viability up to a concentration of 1 mg/mL. On the other
hand, a concentration-dependent reduction in cell viability was demonstrated by CMC 2,
ALG 1 and ALG 2. At 1 mg/mL concentration a significant reduction in cell viability was
produced by these formulations (Figure 8). At a concentration of 0.5 mg/mL, cell viability
was not affected by any of the formulations except ALG 2.
3.5. Macroscopic Examination of In Situ Gelled Polymer/Solvent Blends in Excised Bovine Teats
Following the infusion of each polymer/solvent blend (formulations HPMC 1, HPMC
2, CMC 1, CMC 2, ALG 1 and ALG 2) into excised bovine teats for the specified times (3 and
12 h) at room temperature under conditions of shaking at 50 rpm, teats were cut open and
evaluated for evidence of in situ gelling of the blend formulations. In addition, macroscopic
observations of the condition of the teat and the mucosal tissue in direct contact with the
gelled formulation were made. In particular, the internal mucosal surface of the teat was
scrutinised for any untoward event (colour change, redness, necrosis, inflammation, excess
vascularisation etc.).
Three bovine teats, cut open prior to infusion of any polymer/solvent blends, revealed
healthy looking mucosal lining with firm, turgid tissue, of vibrant colour with no signs
of inflammation or visual evidence of perfuse vascularisation. Although these studies
were qualitative in nature, they clearly showed that all six formulations underwent in situ
phase transitions inside the teat canal after 3 and 12 h. All formulations were well retained
and assumed the shape of the teat cavity lying in close contact to the internal mucosa.
There was no evidence of formulation leakage from the teat orifice during the course of
the experiment.
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For all formulations, gels formed after three hours were less viscous and had a runny
consistency compared with those at twelve hours. In addition, there was no evidence of
gels reverting to the sol state with time as intact gels of all formulations were still visible
even after 12 h (Figure 9).
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ALG 1 after exposure to the infused formulations for 3 and 12 h. (HPMC1 = HPMC 10%, G 49.5%, E 22.5%, W 18%; HPMC2 
= HPMC 10%, G 9%, PG 72%, W 9%; CMC 1 = CMC 10%, G 18%, E 45%, W 27%; CMC 2 = CMC 10%, G 27%, E 45%, W 
18%; ALG 1 = ALG 10%, G 31.5%, PG 31.5%, W 27%; ALG 2 = ALG 10%, G 18%, PG 36%, W 36%; W = water as co-solvent). 
A comparison of HPMC, CMC and ALG formulations revealed that gels formed from 
formulations comprising cellulose derivatives were more viscous and firmly set com-
pared to those formulated using ALG. In addition, these gels were transparent and clear, 
indicating a homogeneous mixture of excipient and solvents. The gels formed from the 
two ALG 1 and ALG 2 suspensions were similar in consistency and appeared to be the 
least viscous compared with those based on CMC and HPMC. At twelve hours, ALG gels, 
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Figure 9. Repres nta ive photographs of the inter l trating in situ formed gels of (a) HPMC 2 (b) CMC 2
(c) LG 1 after exposure to the infused formulations for 3 and 12 h. (HPMC1 = HPMC 10%, G 49.5%, E 22.5 , W 18%;
HPMC2 = HPMC 10 , G 9%, PG 72 , W 9%; CMC 1 = CMC 10 , G 18 , E 45%, W 27%; CMC 2 = CMC 10 , G 27 , E
45%, W 18%; ALG 1 = ALG 10%, G 31.5%, PG 31.5%, W 27%; ALG 2 = ALG 10%, G 18%, PG 36%, W 36%; W = water as
co-solvent).
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A comparison of HPMC, CMC and ALG formulations revealed that gels formed
from formulations comprising cellulose derivatives were more viscous and firmly set
compared to those formulated using ALG. In addition, these gels were transparent and
clear, indicating a homogeneous mixture of excipient and solvents. The gels formed from
the two ALG 1 and ALG 2 suspensions were similar in consistency and appeared to be the
least viscous compared with those based on CMC and HPMC. At twelve hours, ALG gels,
although set, appeared turbid, indicating possible microbial growth or phase separation.
Nevertheless, both ALG 1 and ALG 2 appeared firmer at twelve hours than at three hours,
where they assumed shape of the teat cistern.
A comparison of the HPMC formulations revealed that the gel formed in situ from
HPMC 2 appeared to be more viscous compared to HPMC 1. Among the two CMC
formulations, gel consistency was quite similar in both systems by visual inspection. The
time, high costs and milk contamination risks associated with an in vivo study render
such an ex vivo testing with excised teats attractive for proof-of-concept retention and
biocompatibility studies. Macroscopic analysis of the teats after 3 and 12 h of exposure
to the gelled formulations revealed no untoward event. The internal tissue of the teat
appeared of normal colour, with no visible vascularisation, looked healthy and turgid
with no evidence of inflammation compared to untreated control teats. The higher toxicity
of polymer blends CMC2, ALG1 and ALG2 toward MAC-T cells seen in the MTT assay
(Figure 8) does not correlate with the healthy state of the teat according to macroscopic
observations.
4. Discussion
Intramammary formulations that are used to prevent bovine mastitis would usually
require direct and intimate contact with the epithelial cells of the teat and cistern for
prolonged periods of time spanning the dry and drying off periods. Biocompatibility is
considered an essential requirement for such dosage forms. Biocompatibility is described
as the ability of a product to be used for a specific application without having toxic or
deleterious effects to the intended local environment and to biological function [30,31].
Furthermore, assessment of the cytotoxic potential of individual materials used in its
manufacture is required to minimise any potential harm to the animal while ensuring the
appropriateness of the product for its intended purpose.
Previous studies have shown that MAC-T cells mimic primary mammary epithelial
cells (MEC) and would therefore be a valid alternative to MEC [28]. MAC-T cells require
a population doubling time of approximately 17 h and have undergone more than 350
passages without signs of senescence [32,33].
Further, this cell line was sufficiently sensitive for two of the commonly used direct-
contact methods, the MTT and the LDH assays, for analysing the effects on cell growth
inhibition and/or cell death. The 3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTT) is a standard colourimetric assay for measuring cellular
proliferation and viability in the screening of individual solvents and polymeric materials
as potential candidates for formulation. The assay measures of mitochondrial bioreduction
of a tetrazolium salt to a coloured formazan product by mitochondrial dehydrogenases
in living but not in dead cells [34]. The quantity of the formazan product is directly
proportional to the number of living cells in culture. In this way, the MTT can detect
reversible functional cell damage. On the other hand LDH assay detects the irreversible
cell damage [35]. Lactate dehydrogenase (LDH), a stable cytoplasmic enzyme, catalyses the
reversible reaction between pyruvic and lactic acids present in all living cells. This enzyme
is present in nearly all types of metabolising cells. It rapidly releases into the cell culture
supernatant upon cell death or membrane damage and can be measured quantitatively
to provide an accurate measure of cell viability and cell membrane integrity [15,36,37].
The long-term incubation time of three days used in this study allowed contact of the
test substance with the cells over several cell cycles (~3 cycles), including during their
exponential growth phase. Substances that are toxic are likely to induce membrane damage
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and impairment of the metabolic activity in the cell, which may finally lead to cell lysis
and death.
Our MTT assay results clearly showed that the mitochondrial metabolic activity of
MAC-T cells was not significantly affected by PEO, HPMC, CMC, ALG and XG at a
concentration of 1 mg/mL for up to three days of exposure. The cell viability was always
greater than 80%. No changes in cell morphology were observed when examined under
a light microscope. In particular, HPMC did not reduce the cell viability of MAC-T cells
at any concentration used in this study and the response was comparable with that of the
control. Likewise, CMC did not significantly reduce MAC-T cell viability at a concentration
up to 1 mg/mL for an incubation period of three days, suggesting that CMC is devoid of
cytotoxic effects
ALG and XG also showed very good biocompatibility in both MTT and LDH assays.
The % cell viability was always more than 80% following a 72 h incubation period deter-
mined by the MTT assay. LDH assay and microscopic observation showed these polymers
to be non-toxic to MAC-T cells. Previous studies performed in different cell lines have
demonstrated their low toxicity and biocompatibility [38–41]. However different studies
reported varying results related to toxicity of ALG. These could be associated with the pres-
ence of impurities or the differences in the source of polymers. Paul de Vos [42] reported
that the biocompatibility of a ALG-PLL microcapsule was dependent on the content of the
guluronic acid group. Higher biocompatibility was demonstrated by lower guluronic acid
content microcapsules implanted in the peritoneal cavity of an AO (antiorthostatic) rat.
Similarly, it has been suggested that the cytotoxic effect observed from ALG gel dressing
Kaltostat is due to Ca2+ release [40]. These results shed light on cell polymer interactions
with emphasis on the role of the physicochemical properties of these polymers on their
biocompatibility and efficacy for mastitis treatment [43].
Amongst the PEOs of different molecular weight, PEO N 10 had the lowest molecular
weight (MW 100K). While it appeared to reduce cell viability in a concentration-dependent
manner, i.e., by 18% at a concentration of 1 mg/mL, 9% at 0.5 mg/mL and 6% at 0.1 mg/mL
(Figure 2), such reduction was not significant. Previous studies have reported that PEO
cytotoxicity increases with decreasing molecular weight [44–46]
Carbopols and PCP showed significantly higher toxicity in both assays. A concentration-
dependent cytotoxic effect was observed from CPs and PCP. CPs and PCP at 1 mg/mL
concentration reduced cell viability to below 50%. These results were in agreement with
the results reported in the literature by Adriaens et al. [47], who observed increased mucus
secretion and LDH release with a spray-dried Amoica/carbopol 974 mixture in a mucosal
irritation study of slug mucosa. The membrane damage was more pronounced with a
higher concentration of carbopol in the formulation. Similar results were reported by
Diebold [48] in SIRC cells (rabbit corneal cells) and Debbasch (2000) in human conjunctive
cells, who observed severe toxic effects caused by commercial carbomer gel formulation
after only a 30 min exposure period [49].
CP 971 caused the highest toxicity to MAC-T cells based on our results for both
assays. Furthermore, CP 971 was also found to be the most toxic of all polymers tested,
followed by PCP. These results agree with the results reported by Ugwoke et al. [50],
who found CP 971 to be very toxic to human nasal primary cell culture in vitro and to
rabbit nasal mucosa in vivo. They concluded that this polymer was an inappropriate
vehicle for delivery to the nasal mucosa [50]. CPs are anionic, cross-linked polyacrylic acid
polymers with high viscosity. It has been reported that CPs and PCP are utilised to increase
membrane permeability and hence act as penetration enhancers in formulations. However,
the enhanced permeability could be due to the disruption of the tight junction that increases
paracellular permeability [51,52]. The increased cellular permeability resulting from the
disruption of the cell membrane causes leakage of the intracellular enzyme LDH into the
extracellular fluid [53]. The results of our study demonstrated this. Based on the toxicity
profiles obtained in our study, CP and PCP polymers were not progressed further for use
in formulation development.
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The different physicochemical properties of polymers, such as hydrophobicity, hy-
drophilicity, distribution of charge, crystallinity, average molecular weight and residual
monomer, may contribute and invoke different responses in cells [54]. Considering the
complex interplay between the physicochemical properties and cytotoxic effect of these
polymers on membrane integrity, it is difficult to interpret these results because of the
limited number of materials tested. In general, the toxicity of organic compounds increases
as molecular weight decreases. This is because the solubility and tissue diffusion of such
compounds increases as the molecular weight decreases [55].
All solvents used in this study demonstrated a concentration-dependent cytotoxic
effect. Organic solvents are known to cause an increase in the disrupted area of the
intracellular membrane, causing LDH release and eventual cell death.
Among the solvents investigated in a 0.1–10% concentration range, PEG demonstrated
the highest biocompatibility in both assays compared to G and PG. Total biocompatibility
up to 5% PEG was observed with a decline when the concentration was increased to 10%.
However, this cytotoxicity was significantly reduced compared to G and PG in both assays
at this concentration. PG caused the highest cell death at 5 and 10% concentrations. At these
higher concentrations of solvents, visible signs of cell rounding along with the expansion
of intercellular spaces were observed.
Among the solvents tested in a 0.1–1% concentration range, E was the most biocom-
patible, while NMP and 2-Pyr caused higher toxicity to MAC-T cells as demonstrated in
both assays. Microscopic observations indicated that the cell deaths occurred as early as
3 h after the addition of these solvents. At concentrations greater than 0.25% NMP and
greater than 0.1% 2-Pyr, a marked drop in cell viability was seen. Toxicity with NMP was
also endorsed in a study with rats exposed to 1 mg/L NMP. The animals, while showing
no significant clinical signs at lower concentrations (0.1 and 0.5 mg/L), were lethargic, had
respiratory difficulty and had shown excessive mortality while at 1 mg/mL [56].
It has been reported that the rank order for release of creatine kinase enzyme from iso-
lated rat muscles following injection of 40% v/v solution was PG > E > PEG [57]. In another
study, PEG caused lower death rate of cultured endothelial cells (HUV-EC) compared to
E [58].
The data obtained for the MTT and LDH for the polymers and solvents tested showed
good correlation (results not shown), which further validated the results. Based on the
biocompatibility profiles, the polymers HPMC, CMC and ALG, as well as solvents G,
PG and E, were selected for further development of in situ gel formulations for inter-
mammary administration. The polymer–solvents sol blends formed in situ gels following
administration to excised teats in conditions simulating the natural teat environment. The
formation of a different microstructure (of the gel) in situ, and the presence of co-solvents
as part of the formulation may influence cell viability. Consequently, the cytotoxicity
of the formulations over a 0.05–1 mg/mL concentration range was evaluated. Results
determined by MTT assay showed that formulations HPMC 1, HPMC 2 and CMC 1 had
no effect on MAC-T cell viability up to the highest concentration tested. On the other hand,
a concentration-dependent reduction in cell viability was observed with CMC 2, ALG 1
and ALG 2. At 1 mg/mL of blend, a significant reduction in cell viability was induced
by these formulations (Figure 7). At a concentration of 0.5 mg/mL, cell viability was not
affected by any of the formulations except ALG 2 which contained 10% alginate, 18% G,
36% PG and 36% water. The results seen with formulation ALG2 may be attributable to
the concentrations of the solvents and co-solvent, contamination or a combination of these.
The toxicity of the solvent PG at 5 and 10% was shown previously in Figure 6. Both G and
the high concentrations of water in this formulation may have increased the sensitivity of
the MAC-T cells and contributed to hypotonic stress conditions created over the prolonged
incubation period, hence inducing cell lysis. Selzner et al. [59] demonstrated that exposure
of cells to distilled water for more than 15 min was associated with significant increases in
LDH levels and cell lysis.
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The mammary gland of a cow is very sensitive and susceptible to provocation by the
introduction of foreign materials, which, if harmful, is likely to manifest as an inflammatory
event. Our ex vivo teat model took advantage of this to visualise any visual signs of an
inflammatory effects of the in-situ gelling formulations to the teat tissue over the period
of study.
Retention studies in excised mammary glands demonstrated that all formulations
were gelled in three hours. All the formulations were well retained and demonstrated
macroscopic biocompatibility with no signs of local irritation or inflammation inside the
teat canal while agitated at 50 RPM for the experimental period of up to 12 h. There was no
evidence of inflammation, hyperaemia, clotting, redness or necrosis. These observations
further supported the in vitro cell viability testing. These formulations could potentially
be of value as insertable/implantable mucoadhesive systems for sustained intramammary
drug delivery [60,61].
5. Conclusions
In this study, the effect of different hydrophilic polymers and solvents on MAC-T
bovine mammary epithelial cells was investigated. Two assays quantifying the influence of
polymers and solvents on the metabolic activity and the membrane integrity of the cells
were employed. The results indicated that, except for CPs and PCP, all other polymers
studied were biocompatible, as shown by both assays.
Solvents studied induced concentration-dependent cytotoxicity to MAC-T cells. Amongst
those studied, 2-Pyr followed by NMP were the most toxic; PEG followed by G, PG and E
were the least toxic to MAC-T cells.
In situ gelling formulations HPMC1, HPMC2 and CMC2 blends showed no signs of
local undesirable effects using the ex vivo teat model. These in situ gel-forming formula-
tions appeared to be promising as internal teat seals for the prevention of bovine mastitis
over the dry and drying off periods. Further, they could provide a platform to develop
sustained release intramammary drug delivery systems.
The approach adopting biocompatibility and cytotoxicity studies alongside formula-
tion development enabled screening and selection of candidate materials at an early stage
of intramammary dosage form development.
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